Medical Devices News and Research

RSS

Medtronic enters definitive agreement to acquire Salient Surgical Technologies

Medtronic, Inc. today announced that it has entered into a definitive agreement to acquire Salient Surgical Technologies, Inc., the leader in the advanced energy category for haemostatic sealing of soft tissue and bone in a variety of surgical procedures including orthopaedic surgery, spine, open abdominal and thoracic procedures.

From Medtronic 8 Jul 2011

Viewpoints: Preserving Medicaid; drug risks, headlines; health law flaw

The poor and disabled people who rely on Medicaid to pay their medical bills could be in grave jeopardy in this sour I've-got-mine political climate. Older Americans, a potent voting bloc, have made clear that they won't stand for serious changes in Medicare. Medicaid, however, provides health insurance for the most vulnerable, who have far less political clout.

7 Jul 2011

Baltimore symposium to discuss human factors and ergonomics in health-care

The Human Factors and Ergonomics Society invites you to attend the 2012 Symposium on Human Factors and Ergonomics in Health Care, to be held March 12-14, 2012, at the Marriott Baltimore Waterfront Hotel in Baltimore, Maryland. Mark your calendars for this exciting first-time event.

6 Jul 2011

Golden Meditech total turnover increases 15% to HK$328,066,000 for year ended 31 March, 2011

Golden Meditech Holdings Limited, a leading integrated healthcare enterprise in China, is pleased to announce the Group's annual results for the year ended 31 March, 2011.

30 Jun 2011

MEDICREA launches GRANVIA-C pre-IDE pilot trial for treatment of spinal pathologies

The MEDICREA Group, listed on Alternext by NYSE Euronext Paris, a medical device company specialized in the development of innovative surgical technologies for the treatment of spinal pathologies, reaffirmed its ambitious marketing schedule today for GRANVIA-C, its next-generation cervical disc prosthesis, and also announced the launch of a pre-IDE pilot trial with a view to initiating the approval process in the United States.

30 Jun 2011

Suneva Medical receives Health Canada marketing approval for Bellafill

Suneva Medical, a privately-held aesthetic medical device company, today announced the expansion of its core aesthetics injectable business with approval from Health Canada to market Bellafill™, its long lasting dermal filler for nasolabial folds or smile line correction.

29 Jun 2011

bioMD changes name to Allied Healthcare Group

bioMD Limited (ASX: BOD) today announced a change of corporate name to reflect the merger with Allied Medical Ltd earlier this month. The new Company will be called Allied Healthcare Group Ltd and trade under the ASX code AHZ.

28 Jun 2011

'MRA Fusion' treatment for uterine fibroids

A radiologic technology, which functions like a 'human GPS system,' and provides more precise results while using less radiation, is being used to treat patients with symptomatic uterine fibroids exclusively at Paoli Hospital. Dr. Atul Gupta, director of interventional radiology, is treating patients as part of a first-ever clinical trial.

27 Jun 2011

NovaSom completes $35M equity financing led by Safeguard Scientifics

NovaSom, Inc., the market leader in technology-driven, payer-aligned cost-saving solutions for Obstructive Sleep Apnea (OSA) management, today announced it has closed $35 million in equity financing.

27 Jun 2011

Cardiovascular Systems included in latest Russell 2000 Index

Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, has been added to the Russell 2000® Index.

27 Jun 2011

Teleflex, Premier sign new three-year agreement for laryngoscopes

Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, has announced a new three-year agreement with Premier Purchasing Partners, L.P., the group purchasing unit of the Premier healthcare alliance.

27 Jun 2011

Spectranetics initiates enrollment in EXCITE clinical trial against femoropopliteal IRS

Spectranetics Corporation today announces the first patient enrollment in the EXCITE ISR (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis) clinical trial.

27 Jun 2011

Derma Sciences announces $29 million financing

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced it has closed its previously announced private placement.

27 Jun 2011

Supreme Court sides with drug makers in two decisions

One would shield pharmaceutical companies from most lawsuits filed by people injured by taking generic drugs. The other strikes down a Vermont law that banned some commercial uses — "data mining" — of prescription data.

24 Jun 2011

Department of Defense awards Impel Phase II SBIR grant for blood-brain barrier bypass technology

Impel NeuroPharma, a medical device company whose technology is designed to enable pharmaceutical drugs to bypass the blood-brain barrier and enter the central nervous system (CNS), today announced that it was selected to receive a Phase II Small Business Investigational Research (SBIR) grant from the Department of Defense's Chemical and Biological Defense SBIR Program entitled, "Blood Brain Barrier Drug Delivery of Therapeutics for Chemical Warfare Agents."

24 Jun 2011

Scientific evidence is key driver for gaining reimbursement for MR-guided focused ultrasound

Medical researchers have a critical role to play in gaining optimal health insurance reimbursement for MR-guided focused ultrasound. As Susan Klees, Director of Patient Access for the Focused Ultrasound Surgery Foundation, reports, "Scientific evidence is the key driver for reimbursement, and it all begins with the way studies are designed. Today, research priorities must be grounded in sound science as well as the realities of the marketplace."

24 Jun 2011

SweetSpot registers Diabetes Device Data Transfer service as MDDS with FDA

SweetSpot Diabetes Care, Inc. has registered their Diabetes Device Data Transfer service as a Medical Device Data System (MDDS) with the FDA the Company announced today, while attending the 71st Annual American Diabetes Association Scientific Sessions meeting in San Diego, CA.

24 Jun 2011

BIOTRONIK to introduce Lumax DX system for complete atrial arrhythmia diagnosis

BIOTRONIK SE & Co. KG, a worldwide leader in manufacturing cardiac medical devices, announced today that the innovative new Lumax 540 VR-T DX single-chamber implantable cardiac defibrillator (ICD) and Linoxsmart S DX cardiac lead system will be launched this coming week at the EHRA EUROPACE electrophysiology congress in Madrid, Spain.

24 Jun 2011

Scil Technology receives public research grant for novel rheumatoid arthritis treatments

Scil Technology GmbH, a biopharmaceutical company with core expertise in protein drug development, formulation and analytics, today announced that it has been awarded research funding by the German Federal Ministry of Education and Research (BMBF) under BMBF’s KMU-innovativ scheme. The EUR 0.9 million grant supports Scil Technology’s research program to explore the therapeutic potential of repellent proteins for the treatment of rheumatoid arthritis (RA).

23 Jun 2011

Gaining regulatory approval for new medical devices easier than convincing insurers to provide coverage

What's easier: gaining regulatory approval for a new medical device, or convincing insurers to cover the treatments it provides? According to Susan Klees of the Focused Ultrasound Surgery Foundation, many experts say regulatory approval is the easier task.

23 Jun 2011